DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • India
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
RPGLIFE logo

RPG Life Sciences Limited Stock Price

NSEI:RPGLIFE Community·₹44.6b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

RPGLIFE Share Price Performance

₹2,698.60
318.30 (13.37%)
​
₹3,340.00
Fair Value
₹2,698.60
318.30 (13.37%)
19.2% undervalued intrinsic discount
₹3,340.00
Fair Value
Price ₹2,698.60
AnalystConsensusTarget ₹3,340.00
Mon, 10 Aug 26
Fair Value₹3,340.00
Share Pricen/a

RPGLIFE Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value ₹3.34k 19.2% undervalued intrinsic discount

Specialty Therapies And International Expansion Will Support A Stronger Long Term Earnings Profile

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
RPGLIFE logo
RPG Life Sciences
19.2% undervalued intrinsic discount

Specialty Therapies And International Expansion Will Support A Stronger Long Term Earnings Profile

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Published 10 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
RPGLIFE logo

Specialty Therapies And International Expansion Will Support A Stronger Long Term Earnings Profile

Fair Value: ₹3.34k 19.2% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Excellent balance sheet average dividend payer.

2 Risks
1 Reward
View Full Analysis

RPG Life Sciences Limited Key Details

₹7.3b

Revenue

₹2.7b

Cost of Revenue

₹4.7b

Gross Profit

₹3.5b

Other Expenses

₹1.2b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
72.34
63.81%
16.29%
3.3%
View Full Analysis

About RPGLIFE

Founded
1968
Employees
1366
CEO
Ashok Nair
WebsiteView website
www.rpglifesciences.com

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Recent RPGLIFE News & Updates

User avatar
New Narrative • Aug 10

Specialty Therapies And International Expansion Will Support A Stronger Long Term Earnings Profile

Catalysts About RPG Life Sciences RPG Life Sciences is an integrated pharmaceutical company with branded formulations, global generics and API operations across India and more than 50 export markets. What are the underlying business or industry changes driving this perspective?

Recent updates

No updates

RPG Life Sciences Limited Competitors

SUNPHARMA logo

Sun Pharmaceutical Industries

Symbol: NSEI:SUNPHARMA
Market cap: ₹4.4t
DIVISLAB logo

Divi's Laboratories

Symbol: NSEI:DIVISLAB
Market cap: ₹2.5t
500420 logo

Torrent Pharmaceuticals

Symbol: BSE:500420
Market cap: ₹1.9t
ZYDUSLIFE logo

Zydus Lifesciences

Symbol: NSEI:ZYDUSLIFE
Market cap: ₹1.1t
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide